INS and diabetes mellitus: Another study performed by Berenguer et al. showed higher restenosis rates for insulin-treated DM patients after sirolimus-eluting stenting as well as a non-statistically significant difference for the clinical outcome of target vessel failure (death, MI, or TVR, 17.4 vs 7.7 %, p < 0.07) [25].